Advancing drug-response prediction using multi-modal and -omics machine learning integration (MOMLIN): a case study on breast cancer clinical data
The inherent heterogeneity of cancer contributes to highly variable responses to any anticancer treatments. This underscores the need to first identify precise biomarkers through complex multi-omics datasets that are now available. Although much research has focused on this aspect, identifying bioma...
Main Authors: | Rashid, Md Mamunur, Selvarajoo, Kumar |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Journal Article |
Language: | English |
Published: |
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/180034 |
Similar Items
-
Multi-Omics Alleviates the Limitations of Panel Sequencing for Cancer Drug Response Prediction
by: Artem Baranovskii, et al.
Published: (2022-11-01) -
Towards multi-omics synthetic data integration
by: Selvarajoo, Kumar, et al.
Published: (2024) -
Deep learning and multi-omics approach to predict drug responses in cancer
by: Conghao Wang, et al.
Published: (2022-11-01) -
Drepmel—A Multi-Omics Melanoma Drug Repurposing Resource for Prioritizing Drug Combinations and Understanding Tumor Microenvironment
by: Zachary J. Thompson, et al.
Published: (2022-09-01) -
MOVIS: A multi-omics software solution for multi-modal time-series clustering, embedding, and visualizing tasks
by: Aleksandar Anžel, et al.
Published: (2022-01-01)